Luxembourg - Re-Export of Penicillins or Streptomycins Not in Dosage Forms
Since 2014, Luxembourg Re-Export of Penicillins or Streptomycins Not in Dosage Forms was down by 18.6% year on year. At $427.39 in 2019, the country was ranked number 9 among other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms. Luxembourg is overtaken by Uganda, which was number 8 with $4,987 and is followed by Barbados at $123. New Zealand ranked the highest with $476,039.52 in 2019, that is a fall of 2.3% versus 2018. United States, Saudi Arabia and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +152% per year, while United States recorded the worst performance at -25.7% per year.
| Date | US Dollars |
|---|---|
| 2019 | 427.39 |
| 2018 | 608.72 |
| 2017 | 40.58 |
| 2016 | 14.00 |
| 2015 |
Download all data from 2010 to 2019
How does Luxembourg rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?
| # | 11 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
New Zealand
|
476,039.52 | 2019 | -2.3 % | -7.7 % | View data | |
| 2 |
#2
United States
|
108,118.00 | 2019 | -33.5 % | -25.7 % | View data | |
| 8 |
#8
Uganda
|
4,987.00 | 2016 | NA | NA | View data | |
| 9 |
#9
Luxembourg
|
427.39 | 2019 | -29.8 % | -18.6 % | View data | |
| 10 |
#10
Barbados
|
123.00 | 2018 | +402.0 % | NA | View data | |